» Articles » PMID: 34976872

AMPing Up the Search: A Structural and Functional Repository of Antimicrobial Peptides for Biofilm Studies, and a Case Study of Its Application to , an Emerging Pathogen

Overview
Date 2022 Jan 3
PMID 34976872
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial peptides (AMPs) have been recognized for their ability to target processes important for biofilm formation. Given the vast array of AMPs, identifying potential anti-biofilm candidates remains a significant challenge, and prompts the need for preliminary investigations prior to extensive and studies. We have developed Biofilm-AMP (B-AMP), a curated 3D structural and functional repository of AMPs relevant to biofilm studies. In its current version, B-AMP contains predicted 3D structural models of 5544 AMPs (from the DRAMP database) developed using a suite of molecular modeling tools. The repository supports a user-friendly search, using source, name, DRAMP ID, and PepID (unique to B-AMP). Further, AMPs are annotated to existing biofilm literature, consisting of a vast library of over 10,000 articles, enhancing the functional capabilities of B-AMP. To provide an example of the usability of B-AMP, we use the sortase C biofilm target of the emerging pathogen as a case study. For this, 100 structural AMP models from B-AMP were subject to protein-peptide molecular docking against the catalytic site residues of the sortase C protein. Based on docking scores and interacting residues, we suggest a preference scale using which candidate AMPs could be taken up for further , and testing. The 3D protein-peptide interaction models and preference scale are available in B-AMP. B-AMP is a comprehensive structural and functional repository of AMPs, and will serve as a starting point for future studies exploring AMPs for biofilm studies. B-AMP is freely available to the community at https://b-amp.karishmakaushiklab.com and will be regularly updated with AMP structures, interaction models with potential biofilm targets, and annotations to biofilm literature.

Citing Articles

A Comprehensive Review of Recent Research into the Effects of Antimicrobial Peptides on Biofilms-January 2020 to September 2023.

Fontanot A, Ellinger I, Unger W, Hays J Antibiotics (Basel). 2024; 13(4).

PMID: 38667019 PMC: 11047476. DOI: 10.3390/antibiotics13040343.


Prescription of Rifampicin for Infections Increased the Incidence of with Decreased Susceptibility to Rifampicin in a Hungarian Clinical Center.

Orosz L, Lengyel G, Makai K, Burian K Pathogens. 2023; 12(3).

PMID: 36986404 PMC: 10058903. DOI: 10.3390/pathogens12030481.


'Targeting' the search: An upgraded structural and functional repository of antimicrobial peptides for biofilm studies (B-AMP v2.0) with a focus on biofilm protein targets.

Ravichandran S, Avatapalli S, Narasimhan Y, Kaushik K, Yennamalli R Front Cell Infect Microbiol. 2022; 12:1020391.

PMID: 36329825 PMC: 9623296. DOI: 10.3389/fcimb.2022.1020391.


Mining Amphibian and Insect Transcriptomes for Antimicrobial Peptide Sequences with rAMPage.

Lin D, Sutherland D, Aninta S, Louie N, Nip K, Li C Antibiotics (Basel). 2022; 11(7).

PMID: 35884206 PMC: 9312091. DOI: 10.3390/antibiotics11070952.


-Got Worse by a Pandemic?.

Orosz L, Soki J, Kokai D, Burian K Pathogens. 2022; 11(6).

PMID: 35745539 PMC: 9230073. DOI: 10.3390/pathogens11060685.

References
1.
Chung P, Khanum R . Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect. 2017; 50(4):405-410. DOI: 10.1016/j.jmii.2016.12.005. View

2.
McMullen A, Anderson N, Wallace M, Shupe A, Burnham C . When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug-Resistant, Opportunistic Pathogen. Antimicrob Agents Chemother. 2017; 61(11). PMC: 5655097. DOI: 10.1128/AAC.01111-17. View

3.
Dostert M, Belanger C, Hancock R . Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application. J Innate Immun. 2018; 11(3):193-204. PMC: 6738209. DOI: 10.1159/000491497. View

4.
Ishibashi J, Sagisaka A, Momotani E, Yamakawa M . Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide. Biochem J. 1999; 338 ( Pt 1):29-33. PMC: 1220020. View

5.
Benfield A, Troeira Henriques S . Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms. Front Med Technol. 2022; 2:610997. PMC: 8757789. DOI: 10.3389/fmedt.2020.610997. View